Simaar Samarth Ivf Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 2 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
About Simaar Samarth Ivf
Simaar Samarth Ivf Private Limited (SSIPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 September 2022 (Two years and four months 23 days old ). Its registered office is in Aurangabad, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Atish Ladda, Kriti Pathrikar, and Harshlata Laddha serve as directors at the Company.
Company Details
-
Location
Aurangabad, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85120MH2022PTC390918
-
Company No.
390918
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Sep 2022
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Simaar Samarth Ivf?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Atish Ladda
|
Director | 22-Sep-2022 | Current |
|
Kriti Pathrikar
|
Director | 22-Sep-2022 | Current |
|
Harshlata Laddha
|
Director | 22-Sep-2022 | Current |
Financial Performance of Simaar Samarth Ivf.
Enhance accessibility to Simaar Samarth Ivf's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Simaar Samarth Ivf?
Unlock access to Simaar Samarth Ivf's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Embrogen Embryology Private LimitedKriti Pathrikar is a mutual person
-
Ninad Foundation
Kriti Pathrikar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Simaar Samarth Ivf?
Simaar Samarth Ivf has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Simaar Samarth Ivf, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Simaar Samarth Ivf's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
